Literature DB >> 27081110

Cardiovascular Disease in Women: Clinical Perspectives.

Mariana Garcia1, Sharon L Mulvagh1, C Noel Bairey Merz1, Julie E Buring1, JoAnn E Manson2.   

Abstract

Cardiovascular disease continues to be the leading cause of death among women in the United States, accounting for ≈1 of every 3 female deaths. Sex-specific data focused on cardiovascular disease have been increasing steadily, yet is not routinely collected nor translated into practice. This comprehensive review focuses on novel and unique aspects of cardiovascular health in women and sex differences as they relate to clinical practice in the prevention, diagnosis, and treatment of cardiovascular disease. This review also provides current approaches to the evaluation and treatment of acute coronary syndromes that are more prevalent in women, including myocardial infarction associated with nonobstructive coronary arteries, spontaneous coronary artery dissection, and stress-induced cardiomyopathy (Takotsubo Syndrome). Other cardiovascular disease entities with higher prevalence or unique considerations in women, such as heart failure with preserved ejection fraction, peripheral arterial disease, and abdominal aortic aneurysms, are also briefly reviewed. Finally, recommendations for cardiac rehabilitation are addressed.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  acute coronary syndromes; cardiovascular disease; primary prevention; risk factors; women

Mesh:

Year:  2016        PMID: 27081110      PMCID: PMC4834856          DOI: 10.1161/CIRCRESAHA.116.307547

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  215 in total

1.  Screening for abdominal aortic aneurysm: recommendation statement.

Authors: 
Journal:  Ann Intern Med       Date:  2005-02-01       Impact factor: 25.391

2.  Dose response between physical activity and risk of coronary heart disease: a meta-analysis.

Authors:  Jacob Sattelmair; Jeremy Pertman; Eric L Ding; Harold W Kohl; William Haskell; I-Min Lee
Journal:  Circulation       Date:  2011-08-01       Impact factor: 29.690

3.  Arterial imaging outcomes and cardiovascular risk factors in recently menopausal women: a randomized trial.

Authors:  S Mitchell Harman; Dennis M Black; Frederick Naftolin; Eliot A Brinton; Matthew J Budoff; Marcelle I Cedars; Paul N Hopkins; Rogerio A Lobo; JoAnn E Manson; George R Merriam; Virginia M Miller; Genevieve Neal-Perry; Nanette Santoro; Hugh S Taylor; Eric Vittinghoff; Mingzhu Yan; Howard N Hodis
Journal:  Ann Intern Med       Date:  2014-08-19       Impact factor: 25.391

4.  The Yentl syndrome is alive and well.

Authors:  C Noel Bairey Merz
Journal:  Eur Heart J       Date:  2011-03-10       Impact factor: 29.983

5.  Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

6.  Gender differences in the management and clinical outcome of stable angina.

Authors:  Caroline Daly; Felicity Clemens; Jose L Lopez Sendon; Luigi Tavazzi; Eric Boersma; Nicholas Danchin; Francois Delahaye; Anselm Gitt; Desmond Julian; David Mulcahy; Witold Ruzyllo; Kristian Thygesen; Freek Verheugt; Kim M Fox
Journal:  Circulation       Date:  2006-01-31       Impact factor: 29.690

7.  Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment.

Authors:  M M McDermott; P Greenland; K Liu; J M Guralnik; M H Criqui; N C Dolan; C Chan; L Celic; W H Pearce; J R Schneider; L Sharma; E Clark; D Gibson; G J Martin
Journal:  JAMA       Date:  2001-10-03       Impact factor: 56.272

8.  Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial.

Authors:  Margaret M Redfield; Horng H Chen; Barry A Borlaug; Marc J Semigran; Kerry L Lee; Gregory Lewis; Martin M LeWinter; Jean L Rouleau; David A Bull; Douglas L Mann; Anita Deswal; Lynne W Stevenson; Michael M Givertz; Elizabeth O Ofili; Christopher M O'Connor; G Michael Felker; Steven R Goldsmith; Bradley A Bart; Steven E McNulty; Jenny C Ibarra; Grace Lin; Jae K Oh; Manesh R Patel; Raymond J Kim; Russell P Tracy; Eric J Velazquez; Kevin J Anstrom; Adrian F Hernandez; Alice M Mascette; Eugene Braunwald
Journal:  JAMA       Date:  2013-03-27       Impact factor: 56.272

9.  Plasma proneurotensin and incidence of diabetes, cardiovascular disease, breast cancer, and mortality.

Authors:  Olle Melander; Alan S Maisel; Peter Almgren; Jonas Manjer; Mattias Belting; Bo Hedblad; Gunnar Engström; Ute Kilger; Peter Nilsson; Andreas Bergmann; Marju Orho-Melander
Journal:  JAMA       Date:  2012-10-10       Impact factor: 56.272

10.  Use of cardiac rehabilitation by Medicare beneficiaries after myocardial infarction or coronary bypass surgery.

Authors:  Jose A Suaya; Donald S Shepard; Sharon-Lise T Normand; Philip A Ades; Jeffrey Prottas; William B Stason
Journal:  Circulation       Date:  2007-09-24       Impact factor: 29.690

View more
  210 in total

1.  High-Effort Coping and Cardiovascular Disease among Women: A Systematic Review of the John Henryism Hypothesis.

Authors:  Ashley S Felix; Robert Shisler; Timiya S Nolan; Barbara J Warren; Jennifer Rhoades; Kierra S Barnett; Karen Patricia Williams
Journal:  J Urban Health       Date:  2019-03       Impact factor: 3.671

2.  Cholesteryl ester transfer protein alters liver and plasma triglyceride metabolism through two liver networks in female mice.

Authors:  Brian T Palmisano; Thao D Le; Lin Zhu; Yoon Kwang Lee; John M Stafford
Journal:  J Lipid Res       Date:  2016-06-27       Impact factor: 5.922

Review 3.  Sex related differences in the pathogenesis of organ fibrosis.

Authors:  Alejandra Garate-Carrillo; Julisa Gonzalez; Guillermo Ceballos; Israel Ramirez-Sanchez; Francisco Villarreal
Journal:  Transl Res       Date:  2020-03-16       Impact factor: 7.012

4.  Lovastatin protects against cisplatin-induced hearing loss in mice.

Authors:  Katharine Fernandez; Katie K Spielbauer; Aaron Rusheen; Lizhen Wang; Tiffany G Baker; Stephen Eyles; Lisa L Cunningham
Journal:  Hear Res       Date:  2020-02-06       Impact factor: 3.208

Review 5.  The Use of Sex-Specific Factors in the Assessment of Women's Cardiovascular Risk.

Authors:  Anandita Agarwala; Erin D Michos; Zainab Samad; Christie M Ballantyne; Salim S Virani
Journal:  Circulation       Date:  2020-02-17       Impact factor: 29.690

Review 6.  Obesity and cardiovascular disease in women.

Authors:  Camila Manrique-Acevedo; Bhavana Chinnakotla; Jaume Padilla; Luis A Martinez-Lemus; David Gozal
Journal:  Int J Obes (Lond)       Date:  2020-02-17       Impact factor: 5.095

7.  An endovascular model of ischemic myopathy from peripheral arterial disease.

Authors:  Chandler A Long; Lucas H Timmins; Panagiotis Koutakis; Traci T Goodchild; David J Lefer; Iraklis I Pipinos; George P Casale; Luke P Brewster
Journal:  J Vasc Surg       Date:  2016-09-29       Impact factor: 4.268

Review 8.  Bilirubin, a Cardiometabolic Signaling Molecule.

Authors:  Terry D Hinds; David E Stec
Journal:  Hypertension       Date:  2018-10       Impact factor: 10.190

9.  Cutting the Fat.

Authors:  Lia E Taylor; Jennifer C Sullivan
Journal:  Hypertension       Date:  2018-11       Impact factor: 10.190

10.  Does Gender Influence the Relationship Between High Blood Pressure and Dementia? Highlighting Areas for Further Investigation.

Authors:  Anna E Blanken; Daniel A Nation
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.